Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta
Clinical trial NCT00131118 · COMPLETED
Trial details
- NCT number
- NCT00131118
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2007-05-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.